Bill > H2384

This bill modifies the existing Vaccine Program Advisory Council and introduces a provider immunization brand choice requirement. Specifically, the bill revises the composition of the advisory council by maintaining its existing members, which include representatives from various health organizations, medical societies, and state agencies. The bill also changes how the vaccine surcharge is determined, requiring the commissioner of public health to set the annual surcharge by January 1st, with any increase limited to the healthcare cost growth benchmark unless a detailed justification report is submitted. Most significantly, the bill establishes a new requirement that healthcare providers participating in state immunization programs must be able to choose any FDA-licensed or emergency-use authorized vaccine recommended by the CDC's Advisory Committee on Immunization Practices. The department is prohibited from limiting vaccine supply or provider choices, with exceptions during shortages, emergencies, or extraordinary circumstances. The implementation of this provider choice requirement is mandated to be completed by July 1, 2025, and the department is directed to use the CDC's vaccine list for purchasing and administering vaccines. This bill aims to provide more flexibility for healthcare providers in selecting vaccine brands while maintaining regulatory oversight.

Health and Social Services

https://malegislature.gov/Bills/194/H2384